REFERENCES
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: Cancer J Clin. 2011;61:69–90.
- Jemal A, Simard EP, Dorell C, Noone A-M, Markowitz LE, Kohler B et al. Annual report to the Nation on the Status of cancer, 1975–2009, Featuring the Burden and trends in Human Papillomavirus (HPV)–Associated cancers and HPV Vaccination coverage levels. J Nat Cancer Inst. 2013;105:175–201.
- Smith BM, Schwartzman K, Kovacina B, Taylor J, Kasymjanova G, Brandao G et al. Lung cancer histologies associated with emphysema on computed tomography. Lung Cancer. 2012;76:61–66.
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA: Cancer J Clin. 2005;55:74–108.
- Spitz MR, Wei Q, Dong Q, Amos CI, Wu X. Genetic susceptibility to lung cancer the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev. 2003;12:689–698.
- Moore LE, Huang WY, Chung J, Hayes RB. Epidemiologic considerations to assess altered DNA methylation from environmental exposures in cancer. Annals NY Acad Sci. 2003;983:181–196.
- Lu T-P, Tsai M-H, Lee J-M, Hsu C-P, Chen P-C, Lin C-W et al. Identification of a Novel Biomarker, SEMA5A, for Non–Small Cell Lung Carcinoma in Nonsmoking Women. Cancer Epidemiol Biomarkers Prev. 2010;19:2590–2597.
- Lam WK. Lung cancer in Asian women—the environment and genes*. Respirology. 2005;10:408–417.
- Hosgood Iii HD, Boffetta P, Greenland S, Lee Y-CA, Mclaughlin J, Seow A et al. In-home coal and wood use and lung cancer risk: a pooled analysis of the International Lung Cancer Consortium. Environ Health Persp. 2010;118:1743.
- Wu P-F, Lee C-H, Wang M-J, Goggins WB, Chiang T-A, Huang M-S et al. Cancer aggregation and complex segregation analysis of families with female non-smoking lung cancer probands in Taiwan. Eur J Cancer. 2004;40:260–266.
- Jou Y, Lo Y, Hsiao C, Chang G, Tsai Y, Su W et al. Association of an EGFR intron 1 SNP with never-smoking female lung adenocarcinoma patients. Lung Cancer. 2009;64:251.
- Wang T, Yan X, Zhao J, Ye J, Jiang Z, Wu D et al. Gene associated with retinoid-interferon-induced mortality-19 suppresses growth of lung adenocarcinoma tumor in vitro and in vivo. Lung Cancer. 2011;72:287.
- Jirawatnotai S, Hu Y, Michowski W, Elias JE, Becks L, Bienvenu F et al. A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. Nature. 2011;474:230–234.
- Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004;64:3753–3756.
- Xue Q, Zhou Y, Wan C, Lv L, Chen B, Cao X et al. Epithelial membrane protein 3 is frequently shown as promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer. Exp Mol Pathol. 2013;95:313–318.
- Gautier L, Cope L, Bolstad BM, Irizarry RA. affy—analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20:307–315.
- Diboun I, Wernisch L, Orengo CA, Koltzenburg M. Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics. 2006;7:252.
- Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30.
- Harris M, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 2004;32:D258.
- Alvord G, Roayaei J, Stephens R, Baseler MW, Lane HC, Lempicki RA. The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 2007;8:R183.
- Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A et al. STRING v9. 1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41:D808–D15.
- Wingender E. The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation. Brief Bioinform. 2008;9:326–332.
- Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–2504.
- Reverter A, Hudson NJ, Nagaraj SH, Pérez-Enciso M, Dalrymple BP. Regulatory impact factors: unraveling the transcriptional regulation of complex traits from expression data. Bioinformatics. 2010;26:896–904.
- Wu C, Zhu J, Zhang X. Integrating gene expression and protein-protein interaction network to prioritize cancer-associated genes. BMC Bioinformatics. 2012;13:182.
- Cancer IaFRO. World Cancer Report 2014. World Health Organization: Geneva. 2014.
- Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Ann Rev Cell Biol. 1993;9:541–573.
- Reichardt LF, Tomaselli KJ. Extracellular matrix molecules and their receptors: functions in neural development. Ann Rev Neurosci. 1991;14:531.
- Shintani Y, Maeda M, Chaika N, Johnson KR, Wheelock MJ. Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor–β signaling. Amer J Respirat Cell Mol Biol. 2008;38:95.
- Chong I-W, Chang M-Y, Chang H-C, Yu Y-P, Sheu C-C, Tsai J-R et al. Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer. Oncol Reports. 2006;16:981–988.
- Mercier N, Catimel B, Reck M, Pellecchia D, Mcgregor J. Identification of a functional site on CD36 involved in the interaction between platelets and collagen. Platelets. 1995;6:139–145.
- Silverstein RL, Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal. 2009;2:re3.
- Fajas L, Auboeuf D, Raspé E, Schoonjans K, Lefebvre A-M, Saladin R et al. The organization, promoter analysis, and expression of the human PPARγ gene. J Biol Chem. 1997;272:18779–18789.
- Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990;347:645–650.
- Inoue K, Kawahito Y, Tsubouchi Y, Yamada R, Kohno M, Hosokawa Y et al. Expression of peroxisome proliferator-activated receptor (PPAR)-gamma in human lung cancer. Anticancer Res. 2000;21:2471–2476.
- Chang T-H, Szabo E. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor γ in non-small cell lung cancer. Cancer Res. 2000;60:1129–1138.
- Keshamouni VG, Arenberg DA, Reddy RC, Newstead MJ, Anthwal S, Standiford TJ. PPAR-γ activation inhibits angiogenesis by blocking ELR+ CXC chemokine production in non-small cell lung cancer. Neoplasia. 2005;7:294.
- Panigrahy D, Singer S, Shen LQ, Butterfield CE, Freedman DA, Chen EJ et al. PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J Clin Invest. 2002;110:923–932.
- Tas F, Karabulut S, Bilgin E, Duranyildiz D. Serum levels of vascular cell adhesion molecule-1 (VCAM-1) may have diagnostic, predictive, and prognostic roles in patients with lung cancer treated with platinum-based chemotherapy. Tumor Biol. 2014;35:7871–7875.
- Hiratsuka S, Goel S, Kamoun WS, Maru Y, Fukumura D, Duda DG et al. Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation. Proc Nat Acad Sci. 2011;108:3725–3730.
- Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. 2010;123:4195–4200.
- Roussos ET, Condeelis JS, Patsialou A. Chemotaxis in cancer. Nature reviews. Cancer. 2011;11:573.
- Choi YH, Burdick MD, Strieter BA, Mehrad B, Strieter RM. CXCR4, but not CXCR7, discriminates metastatic behavior in non–small cell lung cancer cells. Mol Cancer Res. 2014;12:38–47.
- Song L, Rawal B, Nemeth JA, Haura EB. JAK1 activates STAT3 activity in non-small–cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling. Mol Cancer Ther. 2011;10:481–494.
- Takata Y, Kitami Y, Yang Z-H, Nakamura M, Okura T, Hiwada K. Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-δ and peroxisome proliferator-activated receptor-γ. Circ Res. 2002;91:427–433.
- Min Y, Ghose S, Boelte K, Li J, Yang L, Lin PC. C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α. Oncogene. 2011;30:4901–4909.
- Didon L, Barton JL, Roos AB, Gaschler GJ, Bauer CM, Berg T et al. Lung epithelial CCAAT/enhancer-binding protein-β is necessary for the integrity of inflammatory responses to cigarette smoke. Amer J Respiratory Crit Care Med. 2011;184:233–242.
- Fullard N, Wilson CL, Oakley F. Roles of c-Rel signalling in inflammation and disease. Int J Biochem Cell Biol. 2012;44:851–860.
- Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3:745–756.
- Dougan M, Li D, Neuberg D, Mihm M, Googe P, Wong K-K et al. A dual role for the immune response in a mouse model of inflammation-associated lung cancer. J Clin Invest. 2011;121:2436.
- Zaynagetdinov R, Stathopoulos GT, Sherrill TP, Cheng D-S, Mcloed AG, Ausborn JA et al. Epithelial nuclear factor-κB signaling promotes lung carcinogenesis via recruitment of regulatory T lymphocytes. Oncogene. 2012;31:3164–3176.